Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports

ReutersSep 22, 2025 3:55 AM

Sept 21 (Reuters) - Pfizer PFE.N is closing in on a potential $7.3 billion takeover of anti-obesity drug developer Metsera MTSR.O, the Financial Times reported on Sunday, citing unidentified sources.

Reuters could not immediately confirm the report.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Micron Surges 38% in a Week, Market Cap Breaks 840 Billion, Can This AI Memory Leader Continue the Rally?

TradingKey - Driven by the explosion in AI storage demand, Micron Technology (MU) shares have surged for five consecutive trading sessions since May 1, with a cumulative weekly gain of approximately 38%. The stock closed up over 15% at $746.81 this Friday, hitting a record high. Its market capitalization surpassed $840 billion, with daily turnover reaching $46.36 billion, ranking first in the U.S. stock market.

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

TradingKey — Intel (INTC) shares surged on Friday following reports of a preliminary cooperation agreement with Apple (AAPL). The stock’s intraday gain briefly exceeded 13% before closing up 13.96%, with its market capitalization jumping to $627.8 billion.

Trump’s Shifting Stance Deadlocks US-Iran Talks, Citi Maintains $120 Brent Target

TradingKey - On May 8 (ET), Citi stated that oil prices could rise further if US-Iran negotiations remain deadlocked, maintaining its forecast that Brent crude will reach $120 over the next three months.

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

With a sold-out HBM pipeline, leadership in G9 NAND technology, and a valuation that has yet to fully account for its 2030 trillion-dollar potential, Micron remains a cornerstone "buy" for any long-term tech portfolio.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools